---
title: "Guggenheim Remains a Buy on Cogent Biosciences (COGT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301052620.md"
description: "Guggenheim analyst maintained a Buy rating on Cogent Biosciences today and set a price target of $52.00. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cogent Biosciences with a $55.67 average price target."
datetime: "2026-10-06T15:05:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301052620.md)
  - [en](https://longbridge.com/en/news/301052620.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301052620.md)
generator: "portal-rs"
---

# Guggenheim Remains a Buy on Cogent Biosciences (COGT)

Guggenheim analyst maintained a Buy rating on Cogent Biosciences today and set a price target of $52.00.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cogent Biosciences with a $55.67 average price target.

### Related Stocks

- [COGT.US](https://longbridge.com/en/quote/COGT.US.md)

## Related News & Research

- [Cogent Biosciences files for USD 400 million at-the-market stock offering](https://longbridge.com/en/news/295453309.md)
- [Should FDA Filing Acceptance Require Action From Cogent Biosciences Stock Investors?](https://longbridge.com/en/news/299403530.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [Darling Ingredients (DAR) Could Be 31% Undervalued On Reaffirmed Guidance And Product Launch](https://longbridge.com/en/news/302994330.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**